GSK Selects Wave Hepatic siRNA Candidate

Company Wave Life Sciences / GSK Event Type Deal / Candidate Selection Modality GalNAc-Conjugated siRNA (SpiNA Design) Asset Undisclosed Hepatic siRNA Candidate Target Undisclosed Disease Area Hepatology Summary GSK selected an undisclosed hepatology siRNA candidate from its collaboration with Wave Life Sciences for transfer into…